Acesso livre
Acesso livre

Medicina de Emergências

Revisão | O papel da imagem torácica no diagnóstico, tratamento e monitoramento da Covid-19.

3 Nov, 2021 | 11:12h

The role of chest imaging in the diagnosis, management, and monitoring of coronavirus disease 2019 (COVID-19) – Insights into Imaging

Revisão | Lesão cardíaca na Covid-19.

3 Nov, 2021 | 11:10h

Cardiac injury in COVID-19 – Intensive Care Medicine

 

Comentário no Twitter

 

Estudo randomizado | Entre crianças com pneumonia adquirida na comunidade que receberam alta hospitalar ou do departamento de emergência dentro de 48 horas, uma dose menor de amoxicilina oral foi não inferior a uma dose maior, e o tratamento por 3 dias foi não inferior ao curso de 7 dias.

3 Nov, 2021 | 11:05h

Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial – JAMA (gratuito por tempo limitado)

Conteúdos relacionados:

ACP Guidance: Appropriate Use of Short-Course Antibiotics in Common Infections

RCT: 7 days of antibiotic therapy as good as 14 days for afebrile men with urinary tract infection.

RCT: A Seven-days course of antibiotics for the treatment of bloodstream infections by Enterobacterales was noninferior to a 14-days course.

RCT: Among patients with prosthetic joint infection, antibiotic therapy for 6 weeks was NOT shown to be noninferior to antibiotic therapy for 12 weeks and resulted in a higher percentage of patients with unfavorable outcomes.

Randomized Trial: Seven vs. Fourteen Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia

 

Comentário no Twitter

 

Revisão sobre as complicações vasculares na COVID-19.

2 Nov, 2021 | 12:34h

A comprehensive review of vascular complications in COVID-19 – Journal of Thrombosis and Thrombolysis

Revisão | Cetamina para tratamento de dor aguda.

2 Nov, 2021 | 12:16h

Ketamine for the treatment of acute pain – Canadian Medical Association Journal

 

Comentário no Twitter

 

Estudo de coorte | Entre pacientes com infarto do miocárdio com elevação do segmento ST, o diagnóstico concomitante de Covid-19 está associado a aumento de mortalidade intra-hospitalar.

1 Nov, 2021 | 11:01h

Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction – JAMA

Editorial: Myocardial Infarction During the COVID-19 Pandemic – JAMA

Comentário: STEMI and COVID-19 Often a Lethal Combo, Affirms Largest Study Yet – TCTMD

 

Comentário do autor no Twitter (fio – clique para saber mais)

 

Revisão | Como abordar um paciente com bacteriemia por Staphylococcus aureus resistente à meticilina.

1 Nov, 2021 | 10:50h

How I manage a patient with MRSA bacteraemia – Clinical Microbiology and Infection

Diretriz AHA/ACC 2021 para avaliação e diagnóstico de dor torácica.

29 Out, 2021 | 14:49h

2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines – Journal of the American College of Cardiology

Resumo executivo: 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain – Journal of the American College of Cardiology

Comunicado de imprensa: First-Ever Guideline Focused Solely on Chest Pain Evaluation, Diagnosis Released

Foco da diretriz: Guideline for the Evaluation and Diagnosis of Chest Pain

Pontos principais: 2021 AHA/ACC Chest Pain Guideline – American College of Cardiology

Comentário: New Chest Pain Guidelines Out at Last: Most Tests Have a Role – TCTMD

 

Comentário no Twitter (fio – clique para saber mais)

 

Lesão cerebral após parada cardíaca: fisiopatologia, tratamento e prognóstico.

29 Out, 2021 | 14:35h

Brain injury after cardiac arrest: pathophysiology, treatment, and prognosis – Intensive Care Medicine

 

Comentário no Twitter

 

Estudo randomizado | Tratamento precoce com fluvoxamina reduziu o risco de cuidado de emergência e internação entre pacientes com COVID-19.

28 Out, 2021 | 16:22h

Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial – The Lancet Global Health

Comentários:

Expert reaction to study looking at fluvoxamine as a COVID-19 treatment in high-risk outpatients with early-diagnosed COVID-19 – Science Media Centre

The TOGETHER Trial: COVID-19 and Fluvoxamine Take Two – REBEL EM

The antidepressant fluvoxamine can keep COVID-19 patients out of the hospital – ScienceNews

Conteúdos relacionados:

[Preprint] RCT: Fluvoxamine reduced the risk for ER visits and hospitalization among patients with Covid-19.

Opinion | Could this be our first effective, inexpensive, widely available outpatient treatment for COVID-19? (It’s fluvoxamine).

Preliminary study shows fluvoxamine may reduce clinical deterioration in outpatients with symptomatic COVID-19

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.